Literature DB >> 12789571

The gene for Stargardt disease, ABCA4, is a major retinal gene: a mini-review.

Robert K Koenekoop1.   

Abstract

The gene ABCA4 encodes the rod and cone photoreceptor Rim protein, which is a transmembrane transporter of vitamin A intermediates. ABCA 4 mutations are responsible for a large variety of retinal degenerations including all cases of Stargardt macular dystrophy and fundus flavimaculatus, some forms of cone-rod degeneration, and retinitis pigmentosa, and likely increase the risk of developing age-related macular degeneration (AMD). The purpose of this mini-review is to highlight the advances in our understanding of Stargardt disease and the ABCA4 gene from the first description of the disease by Karl Stargardt in 1909 to gene discovery by Allikmets and colleagues in 1997. The knockout mouse model by Mata and co-workers has provided crucial pathophysiological information that has led to new ideas regarding treatment possibilities. These hypotheses were tested by Radu and colleagues in the mouse and shown to be efficacious.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12789571     DOI: 10.1076/opge.24.2.75.13996

Source DB:  PubMed          Journal:  Ophthalmic Genet        ISSN: 1381-6810            Impact factor:   1.803


  41 in total

Review 1.  Allelic and phenotypic heterogeneity in ABCA4 mutations.

Authors:  Tomas R Burke; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2011-04-21       Impact factor: 1.803

2.  Non-viral Gene Therapy for Stargardt Disease with ECO/pRHO-ABCA4 Self-Assembled Nanoparticles.

Authors:  Da Sun; Rebecca M Schur; Avery E Sears; Song-Qi Gao; Amita Vaidya; Wenyu Sun; Akiko Maeda; Timothy Kern; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  Mol Ther       Date:  2019-09-12       Impact factor: 11.454

3.  Posttranslational modifications of the photoreceptor-specific ABC transporter ABCA4.

Authors:  Yaroslav Tsybovsky; Benlian Wang; Faraz Quazi; Robert S Molday; Krzysztof Palczewski
Journal:  Biochemistry       Date:  2011-07-08       Impact factor: 3.162

4.  Stable Retinoid Analogue Targeted Dual pH-Sensitive Smart Lipid ECO/pDNA Nanoparticles for Specific Gene Delivery in the Retinal Pigment Epithelium.

Authors:  Da Sun; Rebecca M Schur; Avery E Sears; Song-Qi Gao; Wenyu Sun; Amirreza Naderi; Timothy Kern; Krzysztof Palczewski; Zheng-Rong Lu
Journal:  ACS Appl Bio Mater       Date:  2020-04-03

5.  Retinoid binding properties of nucleotide binding domain 1 of the Stargardt disease-associated ATP binding cassette (ABC) transporter, ABCA4.

Authors:  Esther E Biswas-Fiss; Stephanie Affet; Malissa Ha; Subhasis B Biswas
Journal:  J Biol Chem       Date:  2012-11-09       Impact factor: 5.157

6.  Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease.

Authors:  Gwenole Quellec; Stephen R Russell; Todd E Scheetz; Edwin M Stone; Michael D Abràmoff
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-06       Impact factor: 4.799

Review 7.  CFTR structure and function: is there a role in the kidney?

Authors:  J Souza-Menezes; M M Morales
Journal:  Biophys Rev       Date:  2009-01-17

8.  Long-term follow-up of autosomal dominant Stargardt macular dystrophy (STGD3) subjects enrolled in a fish oil supplement interventional trial.

Authors:  Rene Choi; Aruna Gorusupudi; Paul S Bernstein
Journal:  Ophthalmic Genet       Date:  2018-01-29       Impact factor: 1.803

Review 9.  Gene therapy for PRPH2-associated ocular disease: challenges and prospects.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Cold Spring Harb Perspect Med       Date:  2014-08-28       Impact factor: 6.915

10.  [Hereditary retinochoroidal dystrophies. Part 2: differential diagnosis].

Authors:  U Kellner; A B Renner; H Tillack
Journal:  Ophthalmologe       Date:  2004-04       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.